MENU
+Compare
STIM
Stock ticker: NASDAQ
AS OF
Apr 2, 04:59 PM (EDT)
Price
$3.94
Change
+$0.16 (+4.23%)
Capitalization
141.64M

STIM Neuronetics Forecast, Technical & Fundamental Analysis

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders... Show more

STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for STIM with price predictions
Apr 01, 2025

STIM in downward trend: price dove below 50-day moving average on March 28, 2025

STIM moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend. In of 19 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on STIM as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for STIM turned negative on March 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STIM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where STIM advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

STIM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 248 cases where STIM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STIM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.212) is normal, around the industry mean (23.715). P/E Ratio (0.000) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.944) is also within normal values, averaging (41.612).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STIM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

STIM is expected to report earnings to fall 42.42% to -18 cents per share on May 13

Neuronetics STIM Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Missed
by $0.09
Q3'24
Missed
by $0.21
Q2'24
Missed
by $0.06
Q1'24
Beat
by $0.02
The last earnings report on March 04 showed earnings per share of -33 cents, missing the estimate of -23 cents. With 1.12M shares outstanding, the current market capitalization sits at 141.64M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive therapies for psychiatric and neurological disorders

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3222 Phoenixville Pike
Phone
+1 610 640-4202
Employees
203
Web
https://www.neurostar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLOIX8.390.05
+0.60%
Cohen & Steers Future of Energy I
PGVFX32.250.11
+0.34%
Polaris Global Value
FEYCX25.27N/A
N/A
Fidelity Advisor Asset Manager 85% C
VWYIX37.59N/A
N/A
Voya Small Cap Growth R
UEPIX16.38N/A
N/A
ProFunds Europe 30 Inv

STIM and Stocks

Correlation & Price change

A.I.dvisor tells us that STIM and DIZTF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STIM and DIZTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
+2.72%
DIZTF - STIM
31%
Poorly correlated
N/A
FNA - STIM
27%
Poorly correlated
N/A
NEO - STIM
26%
Poorly correlated
-1.48%
ACRS - STIM
25%
Poorly correlated
-3.27%
IART - STIM
24%
Poorly correlated
-1.73%
More